1) prostaglandin E1 methyl ester
前列腺素E1甲酯
1.
Preparation of prostaglandin E1 methyl ester was accomplished by 1,4-addition reaction of organozinc reagent made from 1-iodo-3-trimethysiloxy-1-octene with 2-(6-methoxylcarbonylhexyl)-4-(2-tetrahydro-pyranyloxy)-2-cyclopentenone.
用反-1-碘-3-三甲硅氧基-1-辛烯制备的锌试剂与2-(6-甲氧羰己基)-4-(2-四氢吡喃氧基)-环戊-2-烯酮,经1,4-加成反应合成了前列腺素E1甲酯,这表明用有机锌试剂通过1,4-加成反应合成前列腺素E类化合物是可行的。
2) prostaglandin E 1
前列腺素E1
1.
Objective:To observe both the therapeutic effect and adverse effect of transfusing high concentrated prostaglandin E 1 through Murphy s dropper in different ways to treat lower extremity angiopathy of diabetes patients.
[目的]观察不同方式小壶静脉输注高浓度前列腺素E1治疗老年糖尿病合并下肢血管病变病人的疗效及不良反应。
2.
Objective To study the effect of exogenous prostaglandin E 1 (PGE 1) on the superoxide dismutase(SOD) and nitric oxide(NO) levels in brain tissue of neonatal rats with hypoxic-ischemic brain damage(HIBD).
目的探讨外源性前列腺素E1(PGE1)对缺氧缺血新生大鼠脑组织超氧化物歧化酶(SOD)和NO水平的影响。
3.
Objective To evaluate the influences of Liposomal prostaglandin E 1 (Lipo PGE 1) on clinical liver transplantation by finding out on platelet aggregation, hepatic inflow, liver function, viability of implanted liver and blood coagulation function in patients with liver transplantation.
目的 了解前列地尔 (前列腺素E1的微脂球载体制剂 ,LipoPGE1)对肝移植受体术后血小板聚集功能、肝血供、肝功能及凝血功能、血栓形成的影响 ,以评价前列地尔使用于临床肝移植的意义。
3) prostaglandin E1
前列腺素E1
1.
Prostaglandin E1 Lipid Microspheres Vector(LIPOPGE1)in the Treatment Effect of Sudden Deafness;
前列腺素E1脂微球载体(LIPOPGE1)治疗突发性耳聋疗效分析
2.
Clinical study of Prostaglandin E1 Treatment On Chronic Glomerulonephritis;
前列腺素E1治疗慢性肾小球肾炎临床观察
3.
The protective effect of prostaglandin E1 on lungs during cardiopulmonary bypass;
前列腺素E1在体外循环中调控炎症反应及肺保护作用的研究
4) PGE1
前列腺素E1
1.
Influence of PGE1 on the function of blood platelet in the elder PAOD patients;
前列腺素E1对老年闭塞性周围动脉粥样硬化患者血小板功能的影响
2.
Protective Mechanism of Prostaglandin E1(PGE1) against Liver Cell Apoptosis in Liver Ischemic Reperfusion(I/R) Injury of Rats;
前列腺素E1抗缺血再灌注损伤诱导肝细胞凋亡的作用及分子机制
3.
Observation of the effect of PGE1 on 40 Cases of Pulmonary Heart Disease Companying with Heart Failure;
前列腺素E1治疗肺心病合并心力衰竭40例疗效观察
5) Prostaglandin E_1
前列腺素E1
1.
OBJECTIVE To investigate the protective effect of prostaglandin E_1(PGE_1)on cerebral ischemia reperfusion injury.
目的 探讨前列腺素E1 (PGE1 )对缺血再灌注脑损伤的干预作用。
2.
Protective Effects of Liposome Diluent Prostaglandin E_1 on Myocardial Ischemia Reperfusion Injury During Cardiopulmonary Bypass;
目的探讨前列腺素E1脂肪乳剂(L ipo-PGE1)在体外循环(CPB)中对心肌缺血-再灌注损伤(M IR I)的保护作用。
3.
Effect of prostaglandin E_1 on the expression of tissue inhibitor of metalloproteinase-1 in experimental liver fibrosis rats;
目的:通过研究前列腺素E1(prostaglandin E1,PGE1)对实验性肝纤维化大鼠基质金属蛋白酶组织抑制因子-1(tissue inhibitor of metalloproteinase-1,TIMP-1)的影响,探讨PGE1抗肝纤维化的另一可能机制。
6) PGE 1
前列腺素E1
1.
Objective To discuss the expression of serum TNF-α、IL-6in DM and DNP group and the mechanism of PGE 1 in DNP.
目的观察糖尿病合并神经病变者(DNP)患者血清TNF-α及IL-6的变化;前列腺素E1(PGE1)干预前后的疗效观察及TNF-α,IL-6的变化。
2.
Objective To investigate the efficacy and safety of nimodipine(Nimotop), PGE 1, Lipo PGE 1, kininogenase and methylcobalamin in the treatment of painful diabetic neuropathy.
目的 探讨钙离子拮抗剂(尼莫地平,商品名尼莫同)、前列腺素E1 制剂 [前列地尔 (商品名保达新),前列腺素E1 脂微球制剂(商品名凯时) ]、胰激肽原酶制剂(商品名怡开 )、维生素 (Vit)B12衍生物 (甲钴胺,商品名弥可保)治疗糖尿病痛性神经病变的疗效及安全性。
3.
Objective To observe the role of PGE 1 in heart-lung transplantation.
目的 观察前列腺素E1在心肺联合移植手术中的保护效果。
补充资料：前列腺素 E1
分子式：C20H34O5
分子量：暂无
CAS号：745-65-3
性质：暂无
制备方法：暂无
用途：适用于心肌梗塞、心力衰竭、血栓性脉管炎、慢性动脉闭塞症、视网膜中央静脉血栓等。
分子量：暂无
CAS号：745-65-3
性质：暂无
制备方法：暂无
用途：适用于心肌梗塞、心力衰竭、血栓性脉管炎、慢性动脉闭塞症、视网膜中央静脉血栓等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条